Although LCIS is not cancer, it can make you worry about your increased risk of a future breast cancer. Coping with your diagnosis means finding a long-term way to manage your fear and uncertainty.
These suggestions may help you cope with a diagnosis of LCIS:
Aug. 15, 2014
Learn enough about LCIS to make decisions about your care. Ask your doctor questions about your diagnosis and what it means for your breast cancer risk. Use this information to research your treatment options.
Look to reputable sources of information, such as the National Cancer Institute, to find out more. This may make you feel more confident as you make choices about your care.
Go to all of your screening appointments. You may experience some anxiety before your breast cancer screening exams. Don't let this anxiety keep you from going to all of your appointments. Instead, plan ahead and expect that you'll be anxious.
To cope with your anxiety, spend time doing things you enjoy in the days before your appointment. Spend time with friends or family, or find quiet time for yourself.
Control what you can about your health. Make healthy changes to your lifestyle, so you can feel your best. Choose a healthy diet that focuses on fruits, vegetables and whole grains.
Try to be active for 30 minutes most days of the week. Get enough sleep each night so that you wake feeling rested. Find ways to cope with stress in your life.
- Niederhuber JE, et al., eds. Abeloff's Clinical Oncology. 5th ed. Philadelphia, Pa.: Churchill Livingstone Elsevier; 2014. http://www.clinicalkey.com. Accessed Feb. 17, 2014.
- Breast cancer. Fort Washington, Pa.: National Comprehensive Cancer Network. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed Feb. 17, 2014.
- Sabel MS. Atypia and lobular carcinoma in situ: High risk lesions of the breast. http://www.uptodate.com/home. Accessed March 12, 2014.
- Cameron JL, et al., eds. Current Surgical Therapy. 11th ed. Philadelphia, Pa.: Saunders Elsevier; 2014. http://www.clinicalkey.com. Accessed Feb. 17, 2014.
- Chen WY. Selective estrogen receptor modulators and aromatase inhibitors for breast cancer prevention. http://www.uptodate.com/home. Accessed March 12, 2014.
- SEER stat fact sheet: Breast cancer. National Cancer Institute. http://seer.cancer.gov/statfacts/html/breast.html. Accessed March 12, 2014.
- Moyer VA. Medications for risk reduction of primary breast cancer in women: U.S. Preventive Services Task Force recommendation statement. Annals of Internal Medicine. Sept. 24, 2013. http://annals.org/article.aspx?articleid=1740758. Accessed March 12, 2014.
- Visvanathan K, et al. Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline. Journal of Clinical Oncology. 2013;31:2942.
- Degnim AC, et al. Surgical management of high-risk breast lesions. Surgical Clinics of North America. 2013;93:329.
- Townsend CM Jr, et al. Sabiston Textbook of Surgery: The Biological Basis of Modern Surgical Practice. 19th ed. Philadelphia, Pa.: Saunders Elsevier; 2012. http://www.clinicalkey.com. Accessed Feb. 17, 2014.
- Pruthi S (expert opinion). Mayo Clinic, Rochester, Minn. March 16, 2014.
- Vogel VG, et al. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: The NSABP study of tamoxifen and raloxifene (STAR) P-2 trial. JAMA. 2006;295:2727.